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The Syrian refugee crisis has precipitated a catastrophic outbreak of OldWorld cutaneous leish-
maniasis now affecting hundreds of thousands of people living in refugee camps or trapped in
conflict zones. A similar situation may also be unfolding in eastern Libya and Yemen.
Leishmaniasis has been endemic in Syria for over two centuries, with the first case ever
reported being as early as 1745, when it was known as the “Aleppo boil” [1,2]. Old World cuta-
neous leishmaniasis (CL) is characterized most notably by disfiguring skin lesions, nodules, or
papules, and in the Middle East and North Africa (MENA) region it is primarily caused either
by Leishmania tropica (anthroponotic) or L.major (zoonotic), with some sporadic cases also
caused by L. infantum (Box 1) [3–5]. In North Africa, a chronic form of CL also can be caused
by L. killicki [6–7].
Although Old World CL is generally not fatal, clinical symptoms can lead to disfiguring
scars that result in social stigmatization and psychological consequences. The World Health
Organization (WHO) has estimated that around 2.4 million disability-adjusted life years
(DALYs) are lost due to CL and visceral leishmaniasis (VL) globally [8]; however, the number
of DALYs attributed to CL is still under evaluation. The 2013 Global Burden of Disease Study
determined that CL causes only 41,700 DALYs [9], while other studies have found that these
figures may represent profound underestimates [10,11].
Studies observing the impact of marring CL facial scars have found that the social stigmati-
zation involved leads to anxiety, depression, and decreased quality of life for patients [12]. The
scars can lead to a changed perception of self and can limit individuals’ abilities to participate
in society, further decreasing their social, psychological, and economic well-being, as employ-
ment opportunities become scarce. Women, adolescents, and children are particularly suscep-
tible to the social stigmatization of disfiguring scars [13]. The hardships caused by CL extend
beyond physical symptoms and manifest most prominently in patients’ social, psychological,
and economic well-being. Like many neglected tropical diseases (NTDs), CL not only occurs in
settings of poverty but the disease also has the ability to perpetuate and reinforce poverty, cata-
lyzing a positive feedback loop between disease and poverty [14]. For many of these reasons,
the WHO classifies leishmaniasis as one of 17 NTDs [15], although the cutaneous form is often
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not prioritized in major global health initiatives, unlike the NTDs now targeted by integrated
preventive chemotherapy [11].
Pre-Conflict Old World CL in Syria
Even before the current crisis, the Syrian government has struggled to contain endemic CL.
After a 30-year hiatus during which CL was mostly restricted to Aleppo and Damascus [16],
CL re-emerged in northwestern Syria in 1988 [1,17]. In 1991, the incidence of CL dropped tem-
porarily due to insecticide spraying, but it began to rapidly rise again even as insecticide spray-
ing continued [18]. The increased number of cases may have been accounted for in part by
increased awareness and reporting of the disease; however, the most likely explanation for the
dramatic increase and distribution of CL starting in the early 1990s stems from socioeconomic
and environmental factors [1]. During this time, Syria experienced rapid and decentralized
urbanization as city suburbs expanded and the population density increased [19]. People began
to migrate from rural to urban areas, and municipal departments, overwhelmed by these
changes, were no longer able to provide adequate hygiene and sanitation services such as trash
collection and disposal, as well as insecticide spraying [1,19]. As populations migrated, individ-
uals with no immunity became exposed to CL and the disease spread [1]. Such factors may
account for a steep rise in the apparent number of CL cases in Syria beginning in 2008 as
reported previously by Salam et al. in PLOS Neglected Tropical Diseases (Fig 1) [20].
The numbers of CL cases in Syria began to increase even further following the onset of the
Syrian Civil War in March, 2011, with new cases appearing in regions previously thought to be
non-endemic.
War, Refugees, and the Emergence of Catastrophic NTDs
While CL is by no means new to Syria [7], the war in Syria has greatly increased the risk for
CL and reports have indicated sharp increases in the number of CL cases in Syria and in sur-
rounding areas of the Middle East [2]. Armed conflict enables outbreaks of serious NTDs
[4,14,21,22] due to a combination of factors—most notably, collapsed health care infrastruc-
tures and population displacement. As populations migrate to endemic and non-endemic
regions, they are exposed to infections for the first time or introduce diseases into new areas,
respectively [4,20,23]. Additionally, the chaos and instability often lends to poor living condi-
tions, which further exacerbate the risk for rapid transmission of infectious diseases [4,14]. In
recent years, such factors were notable for producing catastrophic NTD outbreaks of cholera in
Box 1. Old World Cutaneous Leishmaniasis (CL) in the MENA
Region
Anthroponotic CL
Major etiologic agent: Leishmania tropica [4,5,7]
Major vector: Phlebotomus sergenti [4,5]
Zoonotic CL
Major etiologic agent: L.major [4,5,7]
Minor etiologic agent: L. infantum [4,5]
Vectors: Ph. papatasi for L.major; Ph. perfiliewi, Ph. perniciosus, Ph. longicuspis, and
Ph. ariasi for L. infantum [5]
Major animal reservoirs: Rodents (L.major) and dogs (L. infantum) [4,7]
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the Democratic Republic of Congo and kala-azar in Sudan [24,25]. Additionally, human
migration can be accompanied by deforestation or tumultuous urbanization, which often exac-
erbate disease outbreaks [26]. In West Africa, all of these factors combined to create a “perfect
storm” for the 2014–2015 Ebola virus infection epidemic [27]. The ongoing Syrian conflict has
escalated similar factors of instability and chaos that have been shown by past events, such as
the Ebola epidemic in West Africa, to facilitate infectious disease outbreaks.
As the conflict in Syria approaches its fifth year, over 50% of the public hospitals in Syria
have been destroyed and the health care infrastructure is bordering on nonexistent [28]. Thus
far, an estimated 6.5 million Syrians have been internally displaced [29,30] and an additional
4.4 million Syrians have been externally displaced [31]. Due to the violence, Syrians have been
forced to flee from their homes and seek refuge across the Middle East, North Africa, and,
more recently, Europe [31]; currently, 95% of the over 4 million refugees who have fled Syria
reside in Turkey, Jordan, Lebanon, Iraq, and Egypt (Fig 2) [31]. The mass migration of people
within Syria and the MENA region has put a strain on resources. Internally displaced individu-
als have reported that they are in need of non-food items (including personal hygiene prod-
ucts), health care services, food, shelter, water, and education [32]. Similarly, externally
displaced individuals are often living in overcrowded and unhygienic spaces, commonly with-
out access to many necessary resources, including basic sanitation and waste disposal services,
food, electricity, as well as health care [33–36]; in Lebanon, refugee camps consist mostly of
makeshift houses built out of scrap and rubble or tents [33]. Syria is now the leading producer
Fig 1. Year-wise trend of CL cases reported in Middle East (from Salam et al 2014, PLOS Neglected Tropical
Diseases) [20].
doi:10.1371/journal.pntd.0004545.g001
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of refugees in the world and has contributed significantly to what is considered to be the largest
global refugee crisis since World War II [37,38].
Both inside and outside of Syria, conditions of poverty and malnutrition are prevalent and
living situations are grim as adequate municipal services and necessary resources remain scarce
[33]. The socioeconomic and environmental circumstances created by the conflict in Syria
facilitate risk factors for the continued transmission of CL, and they not only potentiate
increased incidence of CL but also exacerbate the morbidity and mortality of CL after transmis-
sion [14,33]. Ongoing violence in Syria has corresponded with infrastructural instability and
chaotic population migration. It has created a setting in which we have seen the re-emergence
of polio and measles, as well as tuberculosis, hepatitis A, and other infections in Syria and
among displaced Syrian refugees [30,39]. However, the pathognomonic and obvious clinical
features of Old World CL caused by both L. tropica and L.major possibly make it the most visi-
ble sign of disease emerging under the current circumstances.
OldWorld CL and the Current Syrian Crisis
With settings enabling transmission of Old World CL as a backdrop, the number of new cases
has continued to rise. Within Syria, a 2013 study published by the Ministry of Health reported
an incidence rate more than twice as high as the incidence rate reported in Syria between 2004
and 2008 by the WHO. The annual incidence of CL in Syria between 2004 and 2008 was esti-
mated to be 23,000 cases per year [40]. In 2012, 53,000 cases were reported, and in the first half
of 2013 alone, 41,000 cases were reported [41]. Additionally, the number of cases of CL has
most likely been severely underreported [42]; the WHO estimated that the actual incidence of
Fig 2. The displacement of Syrian refugees (data from UNHCR, Syria Regional Refugee Response:
Inter-agency Information Sharing Portal) [31].
doi:10.1371/journal.pntd.0004545.g002
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CL in Syria between 2004 and 2008 was three to five times higher than the reported incidence
[40]. The true number of annual incident and prevalent cases in Syria may therefore exceed
100,000.
Along its border with Syria, Turkey—which has taken more Syrian refugees than any coun-
try thus far [31]—has shown indications of increased prevalence of CL among already endemic
existing populations in correlation with the influx of refugees from Syria [23]. Old World CL
has emerged in Lebanon as well, although the outbreak to date has been largely contained to
refugee populations [33,43,44]. A new report indicates that among the cases of CL observed in
refugee communities in Lebanon, 85% of the cases are caused by L. tropica, with the remainder
caused by L.major [33]. This may complicate treatment in the long term as L. tropica patients
tend to be more refractory to the main CL drug, sodium stibogluconate (SSG) [45–47]. In the
countries that have observed new cases of CL, younger age groups, due to their lack of previous
exposure to the disease, have been the most affected [23,33]. Non-immune existing individuals
also are at great risk of contracting CL as their immune systems are not equipped to fend off
the parasite.
Few countries have mandated reporting of CL [33], and the resultant weak reporting system
promotes a lack of disease awareness and public policies for treatment and prevention. Com-
pounding this problem is the absence of rapid diagnostics and the requirement to have highly
skilled dermatologists and pathologists establish a diagnosis on the basis of clinical presenta-
tion and confirmatory microscopy, respectively. Even then, the sensitivity of microscopy is not
particularly high (68% for L.major and 45% for L. tropica) [48]. The CL clinical presentation is
also often accompanied by a wide spectrum of clinical manifestations that can mimic other
inflammatory and neoplastic diseases, further complicating the diagnosis and reporting of CL
[49,50].
If Old World CL is not addressed promptly, experience warns of a likely outbreak that may
have unanticipated consequences if allowed to erupt. In the early 2000s, an outbreak of CL was
observed after the Iraq War that spread beyond endemic populations and included foreign
troops in the area [43,51]. The 1990s Afghani civil war experience also was notable for its out-
break of CL [52]. The war is estimated to have caused hundreds of thousands of CL cases in
Afghanistan and among refugee populations in Pakistan [52,53].
OldWorld CL and Other Conflict Zones in MENA
Knowledge of Old World CL in Syria and among its refugees is limited; however, we know
even less about the situation in areas of Libya now controlled by the self-proclaimed Islamic
State, or Daesh, and its allied extremist groups [54]. Both zoonotic and anthroponotic disease
cycles have been identified in Libya; however, most of the published literature on CL in Libya
focuses on the zoonotic form, which is caused by L.major. This form is responsible for the
majority of CL cases in Libya, with Ph. papatasi as the main vector, and Psymommys obesus
(fat sand rat) andMeriones libycus (Libyan jird) reported as disease reservoirs [55]. However,
L. tropica anthroponotic CL has also been identified in Nalut and Bani Walid. Interestingly,
both L. infantum and L. donovani have been identified in Nalut as causative for CL [55,56].
Outdoor activities like farming and construction work are highly correlated with disease
emergence as a result of increasing exposure to sandfly bites [57,58]. Recently, the United
Nations High Commissioner for Refugees (UNHCR) reported that 363,067 individuals have
been displaced in Libya due to the ongoing unrest [59]. Re-emergence of CL from mass dis-
placement could occur in areas that have had experience with CL, including Siret, Nalut, Gar-
yan, Bani Walid, Kikla, and Ghudamis. Furthermore, about one million Libyan refugees have
been displaced to Tunisia. Anecdotal reports from Tunisia, where refugee camps have been
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established [60], indicate that cases of leishmaniasis are on the rise, but there is minimal, if
any, documentation.
Leishmaniasis is a hidden NTD in Yemen as well. Approximately 10,000 new cases are
reported annually [61]. These cases are caused by both L. tropica and L. infantum in high alti-
tude regions, including Sa’da, Amr’an, Al Bayda, Ibb, Al Dhale’a, Dhamar, and Sana’a [62,63].
Furthermore, L. donovani, L. tropica, and L. infantum cause CL in regions that belong to the
Tihama Coastal Plain, such as Al Hudaydah, Hajjah, and Ta’izz [62]. The Regional Leishmani-
asis Control Centre (RLCC) reports that half of the clinically resembling CL cases are mucocu-
taneous leishmaniasis and that Yemeni CL patients suffer from both shortage of CL treatment
and inadequate response to treatment [64]. Moreover, the access to health care has been
reduced significantly due to conflict in Yemen and absence of aid. As CL in Yemen is thought
to be caused exclusively by an anthroponotic cycle, the disease prevalence will likely increase as
the rubbish accumulation and lack of sewage system foster the perfect breeding sites for Ph. ser-
genti vector. Although no refugee camps have been deployed as a result of the current Yemeni
conflict, many people are migrating to neighboring countries such as Saudi Arabia, which may
lead to the spreading of anthroponotic CL in the southern Saudi regions. The situations in
Libya and Yemen will need further monitoring.
Discussion and Preliminary Recommendations
Areas of conflict provide for complex circumstances that make accurate data collection and
humanitarian aid inaccessible and impractical. Additionally, there is ongoing dialogue about
the efficacy of humanitarian aid in areas of conflict [65]. Especially with the loss of governmen-
tal control in many areas of Syria, Iraq, and parts of Libya to Daesh, policy recommendations
are nearly impossible to implement in many regions of MENA [2].
Despite the difficulties of navigating current geopolitical circumstances in MENA, more can
be done to address the CL situation in this region. Interventions to prevent and control the
spread of CL must be multilateral in dimension and specific to local circumstances [66]. The
following list of preliminary recommendations to prevent and control CL outbreaks highlights
general policies that have already been proposed by organizations such as the WHO and the
Centers for Disease Control [66–68], and emphasizes refugee camps and communities of dis-
placed individuals living in regions of stability in MENA. The utmost priority of all interven-
tions is to do no harm.
1. Continued improvement of living conditions and hygiene infrastructure for refugees. Clean
water, food, and sanitation services aid basic survival while also aiding the prevention and
control of CL among endemic refugee populations.
2. Implementation of mobile teams in refugee camps consisting of medical professionals expe-
rienced in diagnosing and treating CL. Responsibilities for mobile teams would include dis-
ease (and vector) detection, active surveillance, and providing health care treatment for
patients with CL. Treatment includes sodium stibogluconate (Pentostam) and meglumine
antimoniate (Glucantime), as well as alternatives therapies, such as cryotherapy, if there is a
treatment shortage.
3. Collection of health impact assessments prior to the establishment of refugee camps in
neighboring areas of conflict zones. For example, the extermination of animal reservoirs
before settling displaced individuals can help avoid emerging outbreaks among refugee
communities [7].
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4. Implementation of services to address psychological and economic impacts of CL. The most
devastating consequences of contracting CL are often socioeconomic and psychological.
5. Initiatives addressing community stigma surrounding skin lesions and papules associated
with CL. Additional educational programs in refugee communities to raise awareness of CL
also may be beneficial in preventing outbreaks.
6. Distribution of insecticide treatment, particularly in areas known to be endemic with
anthroponotic cycle, to help prevent contagion. A recent Cochrane analysis has concluded
that insecticides may be effective at reducing the incidence of CL; however, whether insecti-
cides are best applied through indoor spraying, treatment of clothing and bed sheets, or use
of nets remains undetermined [69].
7. Research and development to improve diagnosis, treatment, and prevention methods, as
well as ongoing operational research, monitoring, and evaluation to confirm the effective-
ness of existing approaches. All research and development initiatives should give due con-
siderations to ethical issues of working with refugee populations.
The full extent of the Old World CL epidemic in Syria and in bordering countries, as well as
in Libya and Yemen, remains mostly unknown. An adequate disease burden analysis depends
on programs of active surveillance and disease detection, but these are few and far between due
to the violence and instability. We may be witnessing an epidemic of historic and unprece-
dented proportions, but it has largely been hidden due to lack of specific information. The big-
gest limitation of this paper is the inability to access data due to the difficulties of gathering
accurate and current information from regions of instability. Surveillance is even more chal-
lenging in the current refugee crises due to the unprecedented magnitude of population
migration.
The most effective policies in addressing the potentially devastating CL situation that is
emerging from some conflict zones in MENA are initiatives that will promote disease control
while simultaneously promoting the survival of refugees. Provisions of clean water, food,
hygiene services, and adequate shelter will improve the living conditions of refugees while
simultaneously addressing many of the socioeconomic and environmental risk factors that
make refugees highly susceptible to infectious diseases. For example, makeshift houses allow
sandflies to come in close proximity to human beings and the lack of municipal services creates
conditions that facilitate poor health outcomes.
Recommendations for research include the development of improved rapid diagnosis tests,
possibly similar to the point-of-care diagnostic tests under development for VL [70]. Currently,
diagnoses are performed by specialized dermatologists and can only be confirmed by a stained
smear or culture from a skin lesion, which require laboratory settings. The lack of a rapid diag-
nosis test slows the process of diagnosis and leads to delayed treatment and greater risk for mis-
diagnosis of CL. Development of a commercially available vaccine for Old World CL should
also be made a priority, as one does not currently exist even though it would enhance efficacy
of disease and vector control programs [71,72]. A recent analysis confirms the cost-effective-
ness for a vaccine that targets either NewWorld CL [72] or Old World VL [73]. Additionally,
research assessing how best to address the socioeconomic and psychological impacts of CL
on patients as well as the cultural stigma of papules left by CL would facilitate a more well-
rounded approach to confronting the consequences of CL outbreaks. These research projects
should be specific to the dynamics of local communities and cultures. Micro-financing pro-
grams may alleviate some of the economic hardships often associated with CL; however, the
feasibility of micro-financing programs in conflict-affected communities is still being debated
[74].
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A multifaceted, collaborative approach must be taken to control the incidence of CL [7,75],
with priority given to initiatives that will not only aid in the prevention and control of CL but
also improve the living conditions and survival of refugee populations. The World Health
Assembly already adopted a resolution in 2007 to address the global burden of leishmaniasis
[67], but immediate action must be taken to address the spreading burden of CL in the Middle
East. By no fault of their own, refugees and displaced individuals are often fleeing from one
unimaginable circumstance of horror and violence to another of poverty and disease. Interna-
tional communities have a responsibility to pay greater attention to this pressing issue, and it is
imperative that proactive measures are taken to establish efficient and sustainable initiatives
aimed at diagnosing, treating, and preventing CL as the conflicts in Syria, Iraq, Libya, and
Yemen continue.
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